Bhatnagar N, Kim K, Subbiah J, Park B, Ko E, Seong B
Antiviral Res. 2021; 197:105229.
PMID: 34933043
PMC: 8801234.
DOI: 10.1016/j.antiviral.2021.105229.
Xiong F, Liu X, Gao F, Luo J, Duan P, Tan W
Emerg Microbes Infect. 2020; 9(1):78-87.
PMID: 31894728
PMC: 6968527.
DOI: 10.1080/22221751.2019.1708214.
Ko E, Lee Y, Lee Y, Kim Y, Kim K, Kang S
Antiviral Res. 2018; 156:107-115.
PMID: 29885376
PMC: 6590071.
DOI: 10.1016/j.antiviral.2018.06.004.
Kim Y, Lee Y, Kim M, Lee Y, Kim K, Ko E
Front Immunol. 2017; 8:1730.
PMID: 29276514
PMC: 5727122.
DOI: 10.3389/fimmu.2017.01730.
Ricklin M, Python S, Vielle N, Brechbuhl D, Zumkehr B, Posthaus H
Sci Rep. 2017; 7(1):16379.
PMID: 29180817
PMC: 5703990.
DOI: 10.1038/s41598-017-16419-w.
Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore.
Lau Y, Tang L, Lye D, Ooi E, Leo Y
Hum Vaccin Immunother. 2017; 13(3):551-560.
PMID: 28277090
PMC: 5360136.
DOI: 10.1080/21645515.2016.1246636.
Immune Responses Induced by Recombinant Bacillus Subtilis Expressing the Hemagglutinin Protein of H5N1 in chickens.
Mou C, Zhu L, Yang J, Xu W, Cheng X, Yang Q
Sci Rep. 2016; 6:38403.
PMID: 27982050
PMC: 5159790.
DOI: 10.1038/srep38403.
Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant.
Zheng M, Liu F, Shen Y, Wang S, Xu W, Fang F
Hum Vaccin Immunother. 2015; 11(2):397-406.
PMID: 25607884
PMC: 4514371.
DOI: 10.4161/21645515.2014.995056.
Biological and protective properties of immune sera directed to the influenza virus neuraminidase.
Halbherr S, Ludersdorfer T, Ricklin M, Locher S, Berger Rentsch M, Summerfield A
J Virol. 2014; 89(3):1550-63.
PMID: 25392225
PMC: 4300740.
DOI: 10.1128/JVI.02949-14.
AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection.
Lee Y, Kim M, Lee Y, Hwang H, Cho M, Lee J
Vaccine. 2014; 32(35):4578-4585.
PMID: 24951867
PMC: 4126506.
DOI: 10.1016/j.vaccine.2014.06.040.
Evaluation of antibody response in mice against avian influenza A (H5N1) strain neuraminidase expressed in yeast Pichia pastoris.
Subathra M, Santhakumar P, Narasu M, Beevi S, Lal S
J Biosci. 2014; 39(3):443-51.
PMID: 24845508
DOI: 10.1007/s12038-014-9422-3.
Inflammasomes in antiviral immunity: clues for influenza vaccine development.
Yamazaki T, Ichinohe T
Clin Exp Vaccine Res. 2014; 3(1):5-11.
PMID: 24427758
PMC: 3890450.
DOI: 10.7774/cevr.2014.3.1.5.
Development of universal influenza vaccines based on influenza virus M and NP genes.
Zheng M, Luo J, Chen Z
Infection. 2013; 42(2):251-62.
PMID: 24178189
DOI: 10.1007/s15010-013-0546-4.
Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses.
Li Z, Gabbard J, Mooney A, Gao X, Chen Z, Place R
J Virol. 2013; 87(10):5985-93.
PMID: 23514880
PMC: 3648176.
DOI: 10.1128/JVI.00120-13.
NA proteins of influenza A viruses H1N1/2009, H5N1, and H9N2 show differential effects on infection initiation, virus release, and cell-cell fusion.
Chen Q, Huang S, Chen J, Zhang S, Chen Z
PLoS One. 2013; 8(1):e54334.
PMID: 23349854
PMC: 3551949.
DOI: 10.1371/journal.pone.0054334.
Recombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 challenge.
Li Z, Mooney A, Gabbard J, Gao X, Xu P, Place R
J Virol. 2012; 87(1):354-62.
PMID: 23077314
PMC: 3536412.
DOI: 10.1128/JVI.02321-12.
Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.
Marcelin G, Sandbulte M, Webby R
Rev Med Virol. 2012; 22(4):267-79.
PMID: 22438243
PMC: 3389592.
DOI: 10.1002/rmv.1713.
Mucosal and systemic immune responses induced by recombinant Lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1.
Wang Z, Yu Q, Gao J, Yang Q
Clin Vaccine Immunol. 2011; 19(2):174-9.
PMID: 22131355
PMC: 3272930.
DOI: 10.1128/CVI.05618-11.
A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.
Chang H, Huang C, Wu J, Fang F, Zhang W, Wang F
Virol J. 2010; 7:197.
PMID: 20727202
PMC: 2933593.
DOI: 10.1186/1743-422X-7-197.
Anti N1 cross-protecting antibodies against H5N1 detected in H1N1 infected people.
Frobert E, Bouscambert-Duchamp M, Escuret V, Mundweiler S, Barthelemy M, Morfin F
Curr Microbiol. 2009; 61(1):25-8.
PMID: 20033691
DOI: 10.1007/s00284-009-9571-z.